Alex Silverstein is a Portfolio Manager at Point72 Asset Management where he focuses on biotech investments. Prior to joining Point72, Alex was a healthcare analyst at Ridgeback Capital Management. He began his career in finance at Bear Stearns, Inc. in the Equity Research division. Alex graduated from New York University with a B.A. in economics.